Investor Presentation
Investor Presentation
Brisbane, Sep 27, 2017 AEST (ABN Newswire) - Oventus Medical Ltd (ASX:OVN) provide the latest Investor Presentation.

Oventus - investment highlights

1. Oventus is driving the most significant change the sleep apnoea market has seen for years

2. Two key product ranges, both of which are set to disrupt a large and growing market:

OzVent Airway Technology oral appliance - currently generating revenue

CPAP machine* connector to 02Vent- in late stage development (replaces face mask)

3. Agreement executed in June 2017 with world's largest dental prosthetics supplier, Modern Dental Group. Oventus and Modern now preparing for Modern to distribute Oventus' range globally through their established channels

4. Obstructive Sleep Apnoea (OSA) is a massive market. US$3.8b globally, growing at a CAGR of 15-20% with only 20% of OSA sufferers in care

5. Strong institutional investor interest and solid balance sheet with $8.6m in cash (as at 30/6/17)

* CPAP machine: continuous positive airway pressure machine.

To view the presentation, please visit:
http://abnnewswire.net/lnk/0L6QT92E


About Oventus Medical Ltd

Oventus Medical Ltd (ASX:OVN) is a Brisbane, Australia, based medical device company that has commercialized and brought to market a new sleep treatment platform for the treatment of sleep apnoea and snoring that enhances the treatment outcomes of both oral appliance therapy and CPAP therapy through increased efficacy and greater adherence.

      


Contact

Mr Neil Anderson
Managing Director and CEO
M: 0403 003 475

Kyahn Williamson
WE Buchan
P: 03 9866 4722 or kwilliamson@buchanwe.com.au



Related Companies

Oventus Medical Ltd

ABN Newswire This Page Viewed:  (Last 7 Days: 85) (Last 30 Days: 295) (Since Published: 3277) 
ANALYTICS: LOGIN HERE

Oventus Medical Ltd NEWS: RECENT VISITS (2934)